Oneness Biotech Co., Ltd., a pharmaceutical company based in Taiwan, focuses on developing healthcare drugs for chronic diabetic, dengue hemorrhagic fever, and Rheumatoid Arthritis. With a low risk rating score of 16.5, Oneness Biotech Co., Ltd. operates in the ESG-friendly industry. The company's revenue mainly comes from its New Drug Research and Development segment, in addition to its Agricultural Products Cultivation segment.